Napa Wealth Management Purchases New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Napa Wealth Management bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 4,092 shares of the healthcare conglomerate's stock, valued at approximately $2,393,000. UnitedHealth Group makes up approximately 1.1% of Napa Wealth Management's holdings, making the stock its 13th biggest holding.

A number of other institutional investors also recently bought and sold shares of UNH. International Assets Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after buying an additional 5,290,025 shares in the last quarter. Swedbank AB acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at about $1,117,462,000. Lone Pine Capital LLC acquired a new stake in UnitedHealth Group during the second quarter valued at $480,903,000. Dimensional Fund Advisors LP raised its stake in shares of UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock worth $1,942,956,000 after buying an additional 880,183 shares during the period. Finally, Baillie Gifford & Co. raised its position in shares of UnitedHealth Group by 1,125.4% during the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate's stock worth $455,281,000 after purchasing an additional 821,050 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.4 %

UNH traded down $2.58 during trading on Monday, hitting $589.65. The company's stock had a trading volume of 2,573,771 shares, compared to its average volume of 3,883,106. The stock has a market cap of $542.64 billion, a PE ratio of 38.29, a PEG ratio of 1.74 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The firm's 50 day moving average price is $582.84 and its 200-day moving average price is $549.98.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company's revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm posted $6.56 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on UNH. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. Cantor Fitzgerald raised their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an "overweight" rating in a research note on Wednesday, October 16th. Hsbc Global Res lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Thursday, October 17th. Truist Financial reissued a "buy" rating and issued a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Finally, KeyCorp initiated coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an "overweight" rating and a $675.00 target price on the stock. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.